couter

Aemetis, Inc. (AMTX) sells renewable fuels and chemicals, including ethanol, renewable diesel, and sustainable aviation fuel. The company’s next catalyst is Dec 15, 2026 — Strategic Equity Financing / ATM Utilization, which will test its ability to raise capital amid ongoing liquidity challenges and a weak balance sheet. The event will likely reveal whether the company can execute a successful equity offering or ATM share sale without further diluting existing shareholders.

  • Aemetis operates in the specialty chemicals and renewable fuels space, with a focus on low-carbon energy solutions.
  • The company has struggled with negative net income and a large debt load, with shareholders’ equity at -$306.83M as of 2022.
  • Its recent earnings beat in Q2 2026 showed signs of operational recovery, but free cash flow remains negative and volatile.

The Read

Aemetis' stock historically reacted with a median absolute move of ~16% following key catalysts, as seen in its debt refinancing failure, neutral regulatory updates, earnings beat, and underwhelming DOE funding news, with price often settling within prior scenario bands.
Dec 15, 2026 — Strategic Equity Financing / ATM Utilization
Chart by TradingView

The schedule

  • Tue15Dec

    The equity financing event will test the company's ability to manage liquidity and demonstrate the effectiveness of the capital raise in supporting operational and financial performance.

  • Thu11Mar

    The earnings release will test whether AMTX can deliver consistent revenue and margin improvements, following a recent miss that raised concerns about operational execution.

  • Thu13May

    This release will test the company's ability to sustain revenue growth and improve EBITDA margins, following a recent capital raise that may have diluted earnings per share.

  • Thu5Aug

    The release will test whether AMTX can deliver a strong top-line growth and margin expansion, following a recent capital raise that may have impacted liquidity.

  • Thu4Nov

    This release will test the company's ability to maintain momentum in revenue growth and improve EBITDA margins, following a recent capital raise that may have impacted liquidity.

Past

  • Thu5Nov

    Actual outcome: Bear · $0.95 at outcome

    The company reported an EPS actual of -1.24, matching the estimate, but the stock fell 37.5% as guidance signaled continued margin pressure and weak demand outlook. The bear floor was breached, reflecting investor concerns over the company's ability to stabilize performance. The outcome diverged from the bull case due to lack of positive guidance and strategic clarity, pushing the stock below the bear floor.

    The earnings release will test whether the company can deliver a positive guidance reset and margin commentary, which historically has driven more price movement than the actual results. This differs from the last print where the focus was on liquidity and debt refinancing.

  • Wed30Sep

    Actual outcome: Bear · $1.27 at outcome

    The stock fell 28.5% from the event date to the outcome date, missing both the bull target of $1.50 and the bear floor of $0.75. The DOE funding update likely failed to meet expectations, possibly due to delays or reduced grant amounts, which heightened concerns about the company's ability to fund its capital-intensive projects. This lack of positive catalyst led to a sharp decline in investor confidence.

    Crucial update on Department of Energy grants or guaranteed loans to fund the Riverbank SAF and Renewable Diesel plant. This capital is desperately needed to offset the heavy debt load and fund the ongoing $6.5M quarterly capex.

  • Thu6Aug

    Actual outcome: Bull · $1.74 at outcome

    Aemetis reported higher second-quarter revenue and a return to operating profitability, driven by growth in its California ethanol and dairy RNG businesses, along with federal tax credits. The positive operating income and improved economics led to a rally, pushing the stock above the bull target.

  • Wed22Jul

    Actual outcome: Mixed · $1.67 at outcome

    AMTX shares remained completely flat following the Federal RFS mandate and permitting reform signals. The lack of price movement indicates that the EPA's Renewable Volume Obligations (RVOs) and policy updates offered no major surprises or shifts in D3 RIN pricing expectations. As a result, the market viewed the regulatory developments as neutral, leading to a muted, sideways reaction.

    Market evaluation of the Environmental Protection Agency's Renewable Volume Obligations (RVOs) and potential policy shifts. A rollback in RFS mandates would heavily pressure D3 RIN pricing.

  • Wed1Jul

    Actual outcome: Bear · $1.71 at outcome

    Aemetis failed to secure a favorable debt refinancing agreement or covenant waiver to resolve its severe liquidity overhang. With $342M in debt against minimal cash, the lack of a non-dilutive financing solution heightened fears of aggressive equity dilution, driving the stock below the bear floor.

    Aemetis faces a critical liquidity juncture with $342M in debt against just $4.8M in cash. A successful refinancing or covenant waiver is required to avoid aggressive equity dilution.